BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 21830451)

  • 1. Serum levels of antimüllerian hormone in women with regular menstrual cycles.
    Zec I; Tislarić-Medenjak D; Bukovec-Megla Z; Harni V; Kusić Z
    Acta Clin Croat; 2010 Dec; 49(4):405-9. PubMed ID: 21830451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statistically significant changes of antimüllerian hormone and inhibin levels during the physiologic menstrual cycle in reproductive age women.
    Wunder DM; Bersinger NA; Yared M; Kretschmer R; Birkhäuser MH
    Fertil Steril; 2008 Apr; 89(4):927-33. PubMed ID: 17603052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in serum antimüllerian hormone levels across the ovulatory menstrual cycle in late reproductive age.
    Robertson DM; Hale GE; Fraser IS; Hughes CL; Burger HG
    Menopause; 2011 May; 18(5):521-4. PubMed ID: 21178792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
    Elgindy EA; El-Haieg DO; El-Sebaey A
    Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stable serum levels of anti-Müllerian hormone during the menstrual cycle: a prospective study in normo-ovulatory women.
    Tsepelidis S; Devreker F; Demeestere I; Flahaut A; Gervy Ch; Englert Y
    Hum Reprod; 2007 Jul; 22(7):1837-40. PubMed ID: 17485437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
    Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
    Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian reserve in young women with low birth weight and normal puberty: a pilot case-control study.
    Sadrzadeh-Broer S; Kuijper EA; Van Weissenbruch MM; Lambalk CB
    Gynecol Endocrinol; 2011 Sep; 27(9):641-4. PubMed ID: 20807167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoking and AMH levels in women with normal reproductive history.
    Dafopoulos A; Dafopoulos K; Georgoulias P; Galazios G; Limberis V; Tsikouras P; Koutlaki N; Maroulis G
    Arch Gynecol Obstet; 2010 Aug; 282(2):215-9. PubMed ID: 20309569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Müllerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation.
    La Marca A; Malmusi S; Giulini S; Tamaro LF; Orvieto R; Levratti P; Volpe A
    Hum Reprod; 2004 Dec; 19(12):2738-41. PubMed ID: 15459174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Menstrual cycle length in relation to antimüllerian hormone and follicle-stimulating hormone.
    Rashidi BH; Abediasl Z; Tehraninejad ES; Shariat M; Mahdavi A
    J Reprod Med; 2009 May; 54(5):315-8. PubMed ID: 19517697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between anti-Müllerian hormone (AMH) and insulin levels during different tanner stages in daughters of women with polycystic ovary syndrome.
    Sir-Petermann T; Ladrón de Guevara A; Codner E; Preisler J; Crisosto N; Echiburú B; Maliqueo M; Sánchez F; Perez-Bravo F; Cassorla F
    Reprod Sci; 2012 Apr; 19(4):383-90. PubMed ID: 22344736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-mullerian hormone as a predictive factor in assisted reproductive technique of polycystic ovary syndrome patients.
    Aleyasin A; Aghahoseini M; Mokhtar S; Fallahi P
    Acta Med Iran; 2011; 49(11):715-20. PubMed ID: 22131240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment.
    Peñarrubia J; Fábregues F; Manau D; Creus M; Casals G; Casamitjana R; Carmona F; Vanrell JA; Balasch J
    Hum Reprod; 2005 Apr; 20(4):915-22. PubMed ID: 15665015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol.
    Hazout A; Bouchard P; Seifer DB; Aussage P; Junca AM; Cohen-Bacrie P
    Fertil Steril; 2004 Nov; 82(5):1323-9. PubMed ID: 15533354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation in antimüllerian hormone concentration during the menstrual cycle may change the clinical classification of the ovarian response.
    Hadlow N; Longhurst K; McClements A; Natalwala J; Brown SJ; Matson PL
    Fertil Steril; 2013 May; 99(6):1791-7. PubMed ID: 23433830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase (LOOP) events underlying irregular ovulatory menstrual cycles in the menopausal transition.
    Hale GE; Hughes CL; Burger HG; Robertson DM; Fraser IS
    Menopause; 2009; 16(1):50-9. PubMed ID: 18978637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High frequency of discordance between antimüllerian hormone and follicle-stimulating hormone levels in serum from estradiol-confirmed days 2 to 4 of the menstrual cycle from 5,354 women in U.S. fertility centers.
    Leader B; Hegde A; Baca Q; Stone K; Lannon B; Seifer DB; Broekmans F; Baker VL
    Fertil Steril; 2012 Oct; 98(4):1037-42. PubMed ID: 22771028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between the serum luteinizing hormone to folliclestimulating hormone ratio and the anti-Müllerian hormone levels in normo-ovulatory women.
    Lee JE; Yoon SH; Kim HO; Min EG
    J Korean Med Sci; 2015 Mar; 30(3):296-300. PubMed ID: 25729253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of antimüllerian hormone and baseline follicle-stimulating hormone levels.
    Singer T; Barad DH; Weghofer A; Gleicher N
    Fertil Steril; 2009 Jun; 91(6):2616-9. PubMed ID: 18555223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.